Vimarsana
Biggest News Aggregation in the World

Page 13 - Bio Techne News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Bio Techne. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Bio Techne Today - Breaking & Trending Today

Bio-Techne (NASDAQ:TECH) Hits New 1-Year Low at $68.00 - Vimarsana News

Bio-Techne (NASDAQ:TECH) Hits New 1-Year Low at $68.00

Shares of Bio-Techne Co. (NASDAQ:TECH – Get Free Report) hit a new 52-week low during trading on Tuesday . The company traded as low as $68.00 and last traded at $68.44, with a volume of 25900 shares traded. The stock had previously closed at $68.43. Analyst Ratings Changes Several brokerages have recently issued reports on […]

6 Healthcare Stocks Analysts Still Like - Vimarsana News

6 Healthcare Stocks Analysts Still Like

The S&P 500 Health Care sector index is on pace to decline for two straight years for the first time in more than two decades.

Unveiling Bio-Techne (TECH)'s Value: Is It Really Priced Right? A Comprehensive Guide - Vimarsana News

Unveiling Bio-Techne (TECH)'s Value: Is It Really Priced Right? A Comprehensive Guide

An in-depth analysis of Bio-Techne's intrinsic value, financial strength, profitability, and growth prospects

Source: yahoo.com
BTC Capital Management Inc. Sells 235 Shares of Bio-Techne Co. (NASDAQ:TECH) - Vimarsana News

BTC Capital Management Inc. Sells 235 Shares of Bio-Techne Co. (NASDAQ:TECH)

BTC Capital Management Inc. reduced its position in shares of Bio-Techne Co. (NASDAQ:TECH – Free Report) by 3.7% in the second quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 6,191 shares of the biotechnology company’s stock after selling 235 shares during the quarter. BTC Capital Management […]

Bio-Techne Co. (NASDAQ:TECH) Receives $101.78 Average Price Target from Analysts - Vimarsana News

Bio-Techne Co. (NASDAQ:TECH) Receives $101.78 Average Price Target from Analysts

Bio-Techne Co. (NASDAQ:TECH – Get Free Report) has received an average rating of “Moderate Buy” from the nine research firms that are presently covering the firm, Marketbeat reports. Two analysts have rated the stock with a hold rating and seven have assigned a buy rating to the company. The average 1 year price target among […]